Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384380100> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W4384380100 abstract "Although antipsychotics have been available for almost 70 years and greatly improved outcomes for individuals with schizophrenia, all currently available options derive their efficacy from blockade of dopaminergic receptors. However, this mechanism of action leaves many symptoms unresolved and is associated with a significant side effect burden. The mechanisms underlying schizophrenia, which were initially thought to be related to excessive presynaptic dopamine in specific areas of the brain, are now understood to be much more complex and involve structural and molecular changes throughout brain circuits. Consequently, drug discovery efforts have sought new targets in the search for safer and more effective medications that can improve symptoms of schizophrenia and psychosis, including trace amine–associated receptors (TAARs), muscarinic receptors, and serotonergic receptors. Positive phase 2 trial results indicating efficacy and safety of the TAAR1 agonist ulotaront (SEP-363856) and of the muscarinic M1/M4 agonist KarXT (xanomeline plus trospium) for total, positive, and negative symptoms in patients with acute exacerbation of schizophrenia, and of the serotonin 5-HT2A agonist/antagonist pimavanserin in patients with schizophrenia and predominant negative symptoms for negative symptom control are encouraging. Taken together, these data indicate in the context of ongoing phase 3 trial programs that patients with schizophrenia may soon have access to the first non–D2 blocking medication, which could drastically change the treatment landscape and improve outcomes for many of the individuals with schizophrenia who do not fully respond to or cannot tolerate currently available antipsychotic agents that currently all act via postsynaptic dopamine D2 receptor blockade." @default.
- W4384380100 created "2023-07-15" @default.
- W4384380100 creator A5004573198 @default.
- W4384380100 creator A5056944189 @default.
- W4384380100 creator A5072395467 @default.
- W4384380100 date "2022-02-15" @default.
- W4384380100 modified "2023-10-15" @default.
- W4384380100 title "Emerging Treatments in Schizophrenia" @default.
- W4384380100 doi "https://doi.org/10.4088/jcp.su21024ip1" @default.
- W4384380100 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35172048" @default.
- W4384380100 hasPublicationYear "2022" @default.
- W4384380100 type Work @default.
- W4384380100 citedByCount "5" @default.
- W4384380100 countsByYear W43843801002022 @default.
- W4384380100 countsByYear W43843801002023 @default.
- W4384380100 crossrefType "journal-article" @default.
- W4384380100 hasAuthorship W4384380100A5004573198 @default.
- W4384380100 hasAuthorship W4384380100A5056944189 @default.
- W4384380100 hasAuthorship W4384380100A5072395467 @default.
- W4384380100 hasBestOaLocation W43843801001 @default.
- W4384380100 hasConcept C118552586 @default.
- W4384380100 hasConcept C126322002 @default.
- W4384380100 hasConcept C137183658 @default.
- W4384380100 hasConcept C15744967 @default.
- W4384380100 hasConcept C169760540 @default.
- W4384380100 hasConcept C170493617 @default.
- W4384380100 hasConcept C199596767 @default.
- W4384380100 hasConcept C2776244919 @default.
- W4384380100 hasConcept C2776412080 @default.
- W4384380100 hasConcept C2778938600 @default.
- W4384380100 hasConcept C2779727114 @default.
- W4384380100 hasConcept C2780494398 @default.
- W4384380100 hasConcept C44208683 @default.
- W4384380100 hasConcept C513476851 @default.
- W4384380100 hasConcept C71924100 @default.
- W4384380100 hasConcept C98274493 @default.
- W4384380100 hasConceptScore W4384380100C118552586 @default.
- W4384380100 hasConceptScore W4384380100C126322002 @default.
- W4384380100 hasConceptScore W4384380100C137183658 @default.
- W4384380100 hasConceptScore W4384380100C15744967 @default.
- W4384380100 hasConceptScore W4384380100C169760540 @default.
- W4384380100 hasConceptScore W4384380100C170493617 @default.
- W4384380100 hasConceptScore W4384380100C199596767 @default.
- W4384380100 hasConceptScore W4384380100C2776244919 @default.
- W4384380100 hasConceptScore W4384380100C2776412080 @default.
- W4384380100 hasConceptScore W4384380100C2778938600 @default.
- W4384380100 hasConceptScore W4384380100C2779727114 @default.
- W4384380100 hasConceptScore W4384380100C2780494398 @default.
- W4384380100 hasConceptScore W4384380100C44208683 @default.
- W4384380100 hasConceptScore W4384380100C513476851 @default.
- W4384380100 hasConceptScore W4384380100C71924100 @default.
- W4384380100 hasConceptScore W4384380100C98274493 @default.
- W4384380100 hasIssue "1" @default.
- W4384380100 hasLocation W43843801001 @default.
- W4384380100 hasLocation W43843801002 @default.
- W4384380100 hasOpenAccess W4384380100 @default.
- W4384380100 hasPrimaryLocation W43843801001 @default.
- W4384380100 hasRelatedWork W110512677 @default.
- W4384380100 hasRelatedWork W1976392791 @default.
- W4384380100 hasRelatedWork W1985560386 @default.
- W4384380100 hasRelatedWork W2002943255 @default.
- W4384380100 hasRelatedWork W2016349928 @default.
- W4384380100 hasRelatedWork W2032735299 @default.
- W4384380100 hasRelatedWork W2082259276 @default.
- W4384380100 hasRelatedWork W2319429007 @default.
- W4384380100 hasRelatedWork W4237368170 @default.
- W4384380100 hasRelatedWork W4250693265 @default.
- W4384380100 hasVolume "83" @default.
- W4384380100 isParatext "false" @default.
- W4384380100 isRetracted "false" @default.
- W4384380100 workType "article" @default.